Tuan Vu Selected Research

Tuan Vu Research Topics

Disease

17	Myasthenia Gravis 02/2024 - 01/2019
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2023 - 01/2016
4	Body Weight (Weight, Body) 08/2023 - 10/2022
3	Nausea 10/2022 - 12/2014
2	Muscle Weakness 01/2024 - 01/2023
2	Autoimmune Diseases (Autoimmune Disease) 01/2024 - 01/2023
2	Clinical Deterioration 08/2023 - 10/2022
2	Fever (Fevers) 01/2023 - 10/2022
2	Headache (Headaches) 01/2023 - 10/2022
2	Fatigue 01/2021 - 04/2018
2	Multiple Sclerosis 04/2018 - 12/2014
1	Rare Diseases (Rare Disease) 10/2023
1	Meningococcal Infections 08/2023
1	Portal Hypertension 04/2023
1	Hepatitis 04/2023
1	Fibrosis (Cirrhosis) 04/2023
1	Ascites 04/2023
1	Varicose Veins (Varicose Vein) 04/2023
1	Hepatic Encephalopathy 04/2023
1	COVID-19 01/2023
1	Infections 01/2023
1	Neoplasms (Cancer) 01/2023
1	Dermatomyositis (Dermatopolymyositis) 10/2022
1	Thromboembolism 10/2022
1	Breast Neoplasms (Breast Cancer) 04/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2022
1	Pain (Aches) 01/2021
1	Neuralgia (Stump Neuralgia) 01/2021
1	Polyneuropathies (Polyneuropathy) 01/2021
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2021
1	Migraine Disorders (Migraine) 12/2014
1	Tics (Tic) 12/2014
1	Intractable Pain 12/2014
1	Tremor (Tremors) 12/2014
1	Vomiting 12/2014
1	Weight Loss (Weight Reduction) 12/2014
1	Glaucoma 12/2014
1	Epilepsy (Aura) 12/2014
1	Dystonia (Limb Dystonia) 12/2014
1	Dizziness (Lightheadedness) 12/2014

Drug/Important Bio-Agent (IBA)

10	Cholinergic ReceptorsIBA 02/2024 - 01/2019
9	glucose-mannose-glucoseIBA 02/2024 - 01/2019
7	AutoantibodiesIBA 01/2024 - 01/2019
6	ravulizumabIBA 02/2024 - 05/2022
3	zilucoplanIBA 01/2024 - 01/2020
3	Complement Inactivating AgentsIBA 10/2023 - 01/2020
2	Immunoglobulin G (IgG)IBA 01/2024 - 01/2021
2	salicylhydroxamic acid (SHAM)IBA 11/2023 - 01/2019
2	neonatal Fc receptorIBA 01/2023 - 01/2019
2	Intravenous Immunoglobulins (IVIG)FDA Link 10/2022 - 01/2021
2	Immunoglobulin Fc FragmentsIBA 01/2021 - 01/2019
2	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 01/2019
1	4-(3-chlorophenylsulfanyl)piperidineIBA 04/2023
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2023
1	muskIBA 01/2023
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	rozanolixizumabIBA 01/2023
1	B-Cell Maturation AntigenIBA 01/2023
1	Acetylcholine (Acetylcholine Chloride)FDA Link 05/2022
1	taxaneIBA 04/2022
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	Nortriptyline (Aventyl)FDA LinkGeneric 01/2021
1	Pregabalin (Lyrica)FDA Link 01/2021
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2021
1	Mexiletine (Mexitil)FDA LinkGeneric 01/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021
1	Sodium Channel BlockersIBA 01/2021
1	eculizumab FDA Link 01/2021
1	reldesemtivIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	AgrinIBA 01/2020
1	Natalizumab (Tysabri)FDA Link 04/2018
1	Central Nervous System Depressants (CNS Depressants)IBA 12/2014
1	Opioid Analgesics (Opioids)IBA 12/2014
1	CannabinoidsIBA 12/2014

Therapy/Procedure

11	Activities of Daily Living (ADL) 02/2024 - 01/2019
4	Therapeutics 01/2023 - 04/2018
3	Resistance Training 11/2023 - 01/2016
1	Drug Therapy (Chemotherapy) 04/2022